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1. Introduction 
Thyroid hormones are involved in the regulation of basal metabolic state and in oxidative 
metabolism [1]. They can cause many changes in the number and activity of mitochondrial 
respiratory chain components. This may result in the increased generation of reactive 
oxygen species (ROS) [2,3]. Oxidative stress is a general term used to describe a state of 
damage caused by ROS [4]. ROS have a high reactivity potential, therefore they are toxic 
and can lead to oxidative damage in cellular macromolecules such as proteins, lipids and 
DNA [5].  
In fact, the cell contains a variety of substances capable of scavenging the free radicals, 
protecting them from harmful effects. Among the enzymatic antioxidants, are glutathione 
reductase (GR), glutathione peroxydase (GPx), catalase (CAT), superoxide dismutase (SOD), 
while the non-enzymatic antioxidants are glutathione (GSH), vitamin E, vitamin C, β-
carotene, and flavonoids [6]. When ROS generation exceeds the antioxidant capacity of cells, 
oxidative stress develops [7].  
Life means a continuous struggle for energy, which is required to fight against entropy. The 
most effective way to obtain energy is oxidation. Oxidative processes predominantly occur in 
mitochondria [8]. On the other hand, mitochondria are the favorite targets of thyroid 
hormones. During thyroid hormone synthesis, there is a constant production of oxygenated 
water, which is absolutely indispensable for iodine intrafollicular oxidation in the presence of 
thyroid peroxidase. In recent years, the possible correlation between impaired thyroid gland 
function and reactive oxygen species has been increasingly taken into consideration [9].  
Experimental studies and epidemiological data suggest that hyperthyroidism is associated 
with increase in free radical production and lipid peroxide levels [10,11].  
In hypothyroidism, a decrease in free radical production is expected because of the 
metabolic supression brought about by the decrease in thyroid hormone levels [12,13,14].  
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The changes in the levels of the scavengers α-tocopherol, glutathione [15] and coenzyme 
Q[16] and activities of antioxidant enzymes [11]were found to be imbalanced and often 
opposite.  
It is worth mentioning that some of the antithyroid drugs have antioxidant effects[17]. It 
was shown that both methimazole and propylthiouracil abolished or reduced radical 
production by complement attacked thyroid cells and decreased cytokine production[18].  
Antioxidants treatments might be helpful in reducing the oxidative damage due to 
hypothyroidism and hyperthyroidism.  
The available data concerning oxidative stress in both hypothyroidism and hyperthyroidism 
are scarce and controversial. Reviewing the most recent data on the subject, this study aims 
at investigating oxidative stress parameters, antioxidant status markers and their response 
to vitamin E supplementation in hyper- and hypothyroid rats.  
2. Oxidative stress 
A major threat to homeostasis and therefore to the integrity of aerobic organisms arises from 
chemical species possessing one or more unpaired electrons in their outer orbital, called free 
radicals [19]. Oxygen free radicals can develop during several steps of normal metabolic 
events. Although free radicals (FR) have the potential to damage the organism, their 
generation is inevitable for some metabolic processes. The main endogenous sources of free 
radicals are the mitochondrial electron transport chain, the microsomal membrane electron 
transport chain, reactions of oxidant enzymes and auto-oxidation reactions [20,21,22].  
Oxidative stress is a term that was introduced by Sies in 1985 and refers to any situation 
where there is a serious imbalance between the production of FR or reactive oxygen species 
(ROS), called the oxidative load, and the antioxidant defense system. The oxidative load is 
described as ”a measure of the steady-state level of reactive oxygen or oxygen radicals in a 
biological system”[23]. Oxidative stress has been defined as ”a disturbance in the pro-
oxidant-antioxidant balance in favour of the former, leading to potential damage”[24].  
Cells can tolerate moderate oxidative loads by increasing gene expression to up-regulate 
their reductive defense systems and restore the oxidant/antioxidant balance. But when this 
increased synthesis cannot be achieved due to damage to enzymes, or substrate limitations, 
or when the oxidative load is overwhelming, an imbalance persists and the result is 
oxidative stress [25]. Superoxide and hydroxyl radicals, along with non-radical oxygen 
species such as hydrogen peroxide (H2O2) are commonly termed reactive oxygen species 
(ROS) and have the highest biological activity. ROS are produced in all cells, depending on 
the intensity of aerobic metabolism, especially in activated neutrophils, monocytes, smooth 
muscle cells and in endothelial cells [26]. Disequilibrium between ROS production and 
inactivation leads to oxidative stress. ROS also cause injury to the basic cell structures. They 
readily react with macromolecules, such as lipid, protein and DNA molecules, which results 
in degradation of cell membranes and excessive activation or inactivation of enzymes[27]. 
The ultimate effects of ROS activity include mutations, metabolic dysfunction and cell 
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ageing. They in turn are a cause of development of inflammatory processes, oncogenesis 
and impaired organ functioning [28, 29].  
Oxidative stress is considered to play a pivotal role in the pathogenesis of aging and several 
degenerative diseases, such as atherosclerosis, cardiovascular disease, type 2-diabetes and 
cancer [30,31,32]. In order to cope with an excess of free radicals produced upon oxidative 
stress, humans have developed sophisticated mechanisms in order to maintain redox 
homeostasis [33].  
These protective mechanisms either scavenge or detoxify ROS, block their production, or 
sequester transition metals that are the source of free radicals, and include enzymatic and 
non enzymatic antioxidant defenses produced in the body, namely, endogenous[34,35], and 
others supplied with the diet, namely exogenous[36,37].  
Antioxidant enzymes act to scavenge free radicals by converting them to less harmful 
molecules [38]. Among the most known enzymatic antioxidants, we notice superoxide 
dismutase (SOD), glutathione reductase (GR), glutathione peroxydase (GPx) and catalase 
(CAT). SOD catalyzes the dismutation of superoxide anion radical to peroxide (H2O2) and 
molecular oxygen (O2). Catalase, an iron-containing hemoprotein, converts hydrogen 
peroxide to water and oxygen [39]. GPx is an enzyme containing a selenium ion as a cofactor 
[40], and for the catalyzed reaction it requires reduced glutathione (GSH), which is provided 
by glutathione reductase. GPx is one of the most effective antioxidants in erythrocytes. A 
reduction in GPx activity results in increased H2O2 levels and hence severe cellular damage 
is observed [41].  
Non-enzymatic antioxidants, such as glutathione, tocopherols, retinols, and ascorbate, play 
an important role in scavenging ROS.  
3. Toxic effects of H2O2 
The levels of H2O2 reached physiologically in cells vary from a low 0. 001 μM to a maximum 
of 0. 7 μM. When H2O2 is applied to the exterior of cultured cells, the intracellular 
concentrations are approximately 10-fold lower than the extracellular concentrations [42, 
43]. Because there are great variations in the rate of H2O2 degradation in different cell types 
and models, it is difficult to compare concentration-effect relations. In most cell cultures, 
H2O2 in the medium disappears in less than 1 h. At higher concentrations than those that 
have a signaling role, H2O2 induces oxidative stress, DNA oxidation and damage, and 
consequent mutagenesis and apoptosis [42]. For the phagocytes, H2O2 has been designated 
as “the enemy within” [44]. Oxidative stress involves the oxidation of various cellular 
components, proteins, lipids, nucleic acids, etc. The accumulation of oxidatively damaged 
proteins accelerates chaperone-mediated autophagy, which will degrade them [45]. 
Oxidative damage to DNA produces adducts (including 8-oxo-deoxyguanosine and 
thymine glycol), single-strand breaks, and at high levels double-strand breaks [46]. Positive 
Comet assays demonstrate these breaks. The half-life of these damages varies for the various 
lesions (from 9–62 min for the adducts, more for the breaks) [47]. The positive Comet assays 
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for thyroid cells incubated with 50 μM H2O2 disappear by 80% in 2 h [48]. Mutagenesis, if it 
leads to constitutive activation of a protooncogene or to inactivation of tumor suppressor 
genes is carcinogenic, especially if it is combined to a proliferative effect. Thus, H2O2 is 
carcinogenic and has been found to play a role in several human cancers (7) even if it may 
not be sufficient [49]. Conversely, selenium, the essential constituent of protective enzymes, 
prevents tumor development in rats submitted to chemical carcinogenesis [50]. Lack of 
protective systems in knockout mice such as lack of peroxiredoxin or glutathione (GSH) 
peroxidases indeed leads to malignant cancers [51,52]. Transfection of an H2O2-generating 
system transforms epithelial cells [53]. High-level acute H2O2 treatment of various cells in 
vitro leads to apoptosis [54]. This effect has been linked to a loss of GSH and reduced 
glutaredoxin and consequent activation of apoptosis signal-regulating kinase (ASK) and of 
an apoptosis program [55]. These effects are stronger in actively proliferating cells [56]. 
Chronic H2O2 administration at low levels induces senescence in cultured cells in vitro in 
human fibroblasts [57,58]. H2O2 favors inflammation [59], and its inhibitory effect on 
indoleamine dioxygenase, which by depriving lymphocytes of tryptophan is 
immunosuppressive, would enhance immune reactions. It is therefore not astonishing that 
even in relatively short-lived (7 h) neutrophils [60] and macrophages, H2O2 generation is 
tightly regulated by a synergic two-pronged mechanism involving both intracellular 
calcium and diacylglycerol protein kinase C[58,61].  
4. Thyroid hormone synthesis 
The thyroid is a shield-shaped organ in the neck region composed of an outer layer of 
follicular cells and c-cells, which surrounds a lumen that contains colloid. It contributes to the 
body’s energy output by regulation of cardiac rate and output, lipid catabolism, heat 
production, and skeletal growth [62], which explains the wide range of symptoms related to 
thyroid abnormalities. The colloid contains thyroglobulin which is converted into thyroid 
hormone (TH). The luminal side of the follicular cell membrane contains microvilli, which 
greatly increase the surface area of the cell to facilitate transfer of colloid into the follicular cell.  
TH includes thyronine (T3), and thyroxine (T4). T4, and to a lesser extent T3, is synthesized in 
the follicular cell and is propagated by thyroid stimulating hormone (TSH) secreted by the 
pituitary gland. TSH synthesis is propagated by thyrotropin releasing hormone (TRH) 
secreted by the hypothalamus. Several of these processes deal with direct or indirect 
collaboration between the thyroid, hypothalamus, pituitary, or pineal glands [63, 64].  
TH synthesis includes a radical intermediate, creating a need for a ROS reaction as part of the 
organ’s function to maintain homeostasis. Iodination of tyrosine residues, catalyzed by a 
peroxidase enzyme, occurs on the endoplasmic reticulum of the thyroid gland cells. Coupling 
forms various THs [65]. H2O2 is required by peroxidase, and is formed by an enzyme from 
NADPH (nicotinamide adenine dinucleotide phosphate-oxidase) and Ca2+ ions.  
Beginning with active transport of dietary iodide (the rate limiting substrate) into the cell by 
sodium-iodide symporter [65], iodide oxidation and hormone synthesis occur at the apical 
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membrane of the follicular cell. Iodination (organification) and the coupling reaction of 
iodotyrosines require the presence of thyroperoxidase (TPO), a hemoprotein located in the 
apical plasma as well as in the adjacent cytoplasm, endoplasmic reticulum, Golgi complex, 
nuclear envelope.  
The molecular mechanism of iodination consists of a series of successive stages, having 
extremely reactive free radicals as intermediate products. Following the addition of 
oxygenated water (H2O2) to thyroperoxidase (TPO), compound I is formed, which oxidizes 
iodine (I+), and the active iodine form results: the iodinium ion (I+) or the hypoiodite ion (IO-
). These remain bound to thyroperoxidase. Tyrosine residues also bind to thyroperoxidase, 
which favors the organification of iodine with the formation of iodotyrosines: 
monoiodotyrosine (MIT) and diiodotyrosine (DIT). In the absence of iodine, compound I is 
spontaneously converted into a stable compound, compound II, which catalyzes the 
coupling reaction of iodotyrosines, resulting in the formation of thyroid hormones. The 
excess of oxygenated water (H2O2) determines the conversion of compound II to inactive 
compound III. Inactivation is prevented by iodine [66].  
The generation of oxygenated water, as an electron acceptor, is absolutely indispensable for 
thyroperoxidase activity [67]. H2O2 is produced by an NADPH-dependent process on the 
external aspect of the apical plasma membrane of follicular cells. Although various enzyme 
systems, including cytochrome reductases, can support H2O2 production in the thyroid, an 
NADPH-dependent, H2O2 –generating system was detected in thyroid particulate fractions 
that appears to be distinct from cytochrome c reductase. The activation of this NADPH 
oxidase requires Ca2+ ions.  
The mechanism of formation of oxygenated water (H2O2) is controversial; there are two 
theories: The superoxide anion is the primary product of the enzymatic conversion of 
oxygen which, under the action of superoxide dismutase (SOD) will be transformed into 
oxygenated water. The superoxide anion, produced inside the cytoplasm, close to the apical 
membrane, under the action of NADPH-oxidase, is released outside the thyroid follicular 
cell only after its transformation into oxygenated water [68]. Other data suggest that 
oxygenated water is the primary product of the NADPH-oxidase system, and is produced 
outside the thyroid follicular cell via the two-electron reduction of O2 [69].  
The production of oxygenated water is stimulated by TSH-cAMP and phosphatidylinositol-
Ca2+. Other enzymatic systems capable of generating oxygenated water have been 
evidenced: monoamine oxidase, xanthine oxidase, glucose oxidase [66].  
It is necessary to prevent excess or deficiency of H2O2, anything but optimal levels are linked 
to several thyroid diseases and disorders, such as congenital hypothyroidism, 
tumorigenesis, myxedematous cretinism, thyroiditis, and cancer [70, 71].  
Various reports deal with thyroid disorders and H2O2. Normal levels of H2O2 in the body 
vary from 0. 001 mM to 0. 7 mM, but excess “induces oxidative stress, DNA oxidation and 
damage, and consequent mutagenesis and apoptosis” [71]. Several selenoproteins act as a 
protective barrier for thyrocytes from endogenous H2O2 [72]. If DNA damage is 
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perpetuated, it can lead to carcinogenesis. Also, increased levels of H2O2 inhibit iodide 
uptake and organification [73]. Several genetic disorders have been shown to decrease H2O2 
production by creating a partial iodide-organification defect and reducing or eliminating 
hormone production [74]. This led to permanent congenital hypothyroidism in non-TH 
producing individuals, and mild, transient hypothyroidism in low hormone level subjects. 
As an autoregulatory effect, H2O2 production is diminished by high iodide concentration, 
but mildly stimulated by low iodide levels [75].  
As stimulation by TSH permits, monoiodotyrosine (MIT) and diiodotyrosine (DIT) are 
released from the lumen into the follicular cell. Here, ferric TPO product (oxidized by H2O2) 
reacts with DIT to form a radical stabilized by the aromatic ring. Oxidation of either MIT or 
another DIT, followed by coupling, yields T3 and T4, respectively. Coupling in this reaction 
is catalyzed by TPO. TH inhibits production of TSH and TRH, an autoregulatory effect.  
After hormone synthesis, any free iodotyrosine derivative left over is deiodinated quite 
rapidly due to excess iodotyrosine deiodinase, avoiding formation of other iodoamino acids, 
and recycled back into the thyroid. Thus, only T3 and T4 can be found in the thyroid vein’s 
blood supply [76]. T3 is more potent than T4, more rapid in its reaction, and may be the 
active form of excreted T4 that is deiodinized by the target cells [75]. Two general effects of 
TH are described. First, altering the natural level by injection or thyroidectomy showed 
altered metabolism rates for several organs, suggesting the need for TH for energy 
metabolism. This includes the diaphragm, epidermis, gastric mucosa, heart, kidney, liver, 
pancreas, salivary gland, and skeletal muscles. There are also effects of TH on development. 
Hypothyroidism proved to have an effect on the rate and result of development; yet these 
observations were described as quantitative rather than qualitative, and are generally more 
easily reversed than are developmental inadequacies [77]. Still, although TH affects many of 
the body’s cells, it is not considered necessary to the survival of the organism, and removal 
is not uncommon.  
5. Oxidative stress in experimental hyperthyroidism and hypothyroidism 
Thyroid hormones regulate several essential physiological processes such as energy 
metabolism, growth and formation of the central nervous system, tissue differentiation and 
reproduction. The molecular action of thyroid hormones is mediated via the thyroid 
hormone receptors which, after ligand binding, activate genes by binding to the thyroid 
hormone response elements [79].  
Thyroid hormones control the intensity of basal metabolism. They are calorigenic and, 
consequently, they increase oxygen consumption and heat production. Basal metabolism 
decreases in hypothyroidism and increases in hyperthyroidism. In the second case, an 
increase in the number and size of mitochondria, particularly of their cristae, has been seen, 
concomitantly with the increased concentration and the intensified activity of oxidative 
phosphorylation enzymes. T3 and T4 have been found to stimulate in vitro protein synthesis 
in mitochondria, ADP capture, ATP formation and oxygen consumption. The primary 
ligands of T3 are the nucleus and the mitochondrion. In fact, thyroid hormones have 
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primary actions in several cell organelles, in a coordinated succession: binding to the cell 
membrane as a substrate, to mitochondria, through which metabolic energy required for 
nuclear transcription and posttranscription is released, and the specific synthesis of 
structures and functions is directed. Mitochondria are particularly important for the action 
mechanism of thyroid hormones, representing the final step of oxygen transfer in the 
respiratory chain [67].  
Mitochondrial respiration is a complex metabolic process by which hydrogen from the 
reduced forms of dehydrogenases is oxidized to proton (H+) and molecular oxygen from air 
is reduced to anion, which allows for the formation of water. NADPH+H+-dehydrogenase, 
flavoproteins (FMNH2/FADH2), non-porphyrin iron-sulfur proteins, ubiquinones (Q), and 
certain cytochromes participate in the main oxidoreduction reactions of the respiratory 
chain [79]. In mitochondrial respiration, significant amounts of hydrogen superoxide and 
peroxide radicals are formed, probably due to the auto-oxidable nature of the enzymatic 
system components (coenzyme Q, NADH+H+-dehydrogenase, cytochrome b), on the one 
hand, and to the incomplete reduction of the oxygen molecule (“trivalent” reduction occurs 
instead of “tetravalent” reduction), on the other hand. Superoxide formation is continuous 
in the respiratory chain, approximately 1-2% of the electrons that participate in the chain 
form superoxide and its dismutation product – hydrogen peroxide [80].  
Thyroid hormones increase the concentration and activity of Na+-K+ dependent ATP-ase, as 
well as Na+ and K+ permeability. 15% to 40% of the basal energy used by the cell is used for 
the maintenance of an electrochemical gradient. Thyroid hormones concomitantly stimulate 
the activity of cellular anabolic and catabolic enzymes, determining in this way the 
intensification of energy consumption [81].  
Data from in vivo and in vitro studies indicate that thyroid hormones have a considerable 
impact on oxidative stress [11]. The great majority of the reactive oxygen species (ROS) are 
generated at mitochondrial level, via oxidative phosphorylation. Thyroid hormones act on 
mitochondria by regulating energy metabolism, and mitochondria are a major source of 
intracellular free radicals [82,83]. During thyroid hormone synthesis, there is a constant 
production of oxygenated water, which is absolutely indispensable for iodine intrafollicular 
oxidation in the presence of thyroid peroxidase. In recent years, the possible correlation 
between impaired thyroid gland function and reactive oxygen species has been increasingly 
taken into consideration [9].  
The aim of our study was to evaluate oxidative stress parameters, antioxidant status 
markers and their response to vitamin E supplementation in experimental hyperthyroidism 
and hypothyroidism.  
White, male, Wistar rats weighing between 220 and 240 g were purchased from The Iuliu 
Hatieganu University of Medicine and Pharmacy,Cluj-Napoca biobase. All animals were 
kept under the same environmental conditions, at a room temperature of 23±1ºC, with an 
artificial lighting cycle (lights on 08. 00-20. 00 h) and water ad libitum.  
They were divided into 5 groups of 10 animals each: group 1– controls, group 2 – animals 
treated with L-thyroxine 10μg/animal/day for 30 days and group 3 – L-thyroxine treated rats 
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protected with 10 mg/animal/day of vitamin E administered intramuscularly, for 30 days, 
group 4 – animals treated with Propylthiouracil (5mg/100g animal /day), for 30 days and 
group 5 – Propylthiouracil treated rats protected with 10 mg/animal/day of vitamin E 
administered intramuscularly, for 30 days. The L-thyroxine and Propylthiouracil quantity 
dissolved in 2 ml of milk was administered by gavage in the morning on an empty stomach.  
Thirty days into the experiment, blood was taken from the retro orbital sinus and the rats 
were sacrificed by cervical dislocation following ether anaesthesia.  
Thyroid gland was immediately dissected out and placed into ice-cold isolation medium. 
Tissue homogenates were used for analytical procedures.  
Malondialdehyde (MDA), the marker of lipid peroxidation, carbonyl proteins, SH 
groups,reduced glutathion (GSH) and superoxide dismutase (SOD) were determined from 
the serum, while MDA, carbonyl proteins, SH groups and GSH were determined from the 
thyroid tissue homogenates.  
The lipid peroxides level was assessed by fluorescence according to the Conti and Moran 
method [84], based on the reaction between malondialdehyde, the marker of lipid 
peroxidation and thiobarbituric acid, measured spectrophotometrically at 534nm.  
Plasma or tissue homogenates were boiled in 2-thiobarbituric acid solution 10mM in 
K2HPO4 75mM PH3 and extracted on n-butanol consecutively. Concentration values of 
MDA are expressed in nmol / ml based on specific calibration curves.  
Protein oxidation was determined through the estimation of carbonyl groups 
photometrically with dinitrophenylhydrazine according to the Reznick method[85] and 
expressed as nmol per mg of protein (nmol/mg protein). Serum samples were submitted to a 
reaction with 2,4- dinitrophenylhydrazine 10 mM in HCL 2,5N, and treated with 20% 
trichloracetic acid; the precipitate obtained by centrifugation was washed with a 1: 1 (v/v) 
mixture of ethyl acetate and absolute ethylic alcohol and dissolved in guanidine 
chlorhydrate 6M. In the samples thus obtained the protein concentration was determined by 
measuring extinction at 280 nm. The carbonyl concentration was given by the formula 
355C  Abs x 45,45nmol / ml  
The thiol content of samples was determined with dithionitrobenzoic acid (DTNB), 
according to the Hu method [86]. One plasma volume was mixed with Tris (0,25M)- 
EDTA20mM pH 8,2 buffer, absorbance being read at 412 nm. The Ellman( DTNB)10mM 
reagent was added, which produces a staining reaction, and the absorption was determined 
again at the same wave length.  
The results were expressed as nmol SH per milligram of protein (nmol/mg protein).  
Fluorescence was used to determine the glutathione (GSH) values [86]. For the GSH dosage 
one plasma volume was mixed with TCA 10% and then centrifuged, the supernatant 
separated and additioned with 1. 7 ml phosphate buffer pH 8 and 1 ml o-phthalaldehyde. 
Emission intensity was measured at 420 nm at an excitation of 350 nm.  
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Glutathione concentration was determined using a calibration curve made with known 
concentrations of glutathione processed in the same way. The results were expressed as 
micromoles per litre (μmol/l).  
Superoxide dismutase (SOD) activity of the samples was evaluated using the Flohe method 
[87] and expressed as U SOD per milligram of protein (U/mg protein). Dosage was 
performed on lysed erythrocytes at 250C. Superoxide-dismutase (SOD) catalysed the 
superoxideradical (O2‾) dismutation in peroxide (H2O2 ) and oxygen (O2 ).  
The superoxide radical (O2‾) reacts with C ferricytochrome, which can be continuously 
monitored by recording the absorbance at 550 nm. Superoxid-dismutase reduces the 
concentration of superoxide ions and thus inhibits the reduction of the C cytochrome and 
the SOD amount may be thus calculated from the degree of inhibition of the C cytochrome 
using a calibration curve achieved by the known SOD standards. One unit of SOD activity is 
defined as the amount of enzyme able to inhibit the reduction rate of cytochrome C by 50%.  
Serum free-thyroxine (FT4) concentrations were measured with an enzyme immunoassay kit 
(EIAgen Free T4 Kit, Adaltis Italia).  
Significantly higher FT4 (p<0. 001) values were observed in the L-thyroxine administered 
group as compared with the control group. FT4 values of the L-thyroxine and vitamin E-
administered group were significantly decreased in respect to those of the L-thyroxine only 
administered group.  
In the hyperthyroid rats, the MDA levels did not differ significantly from euthyroid values 
(p>0. 05) while in the thyroid tissue, the MDA levels were significantly decreased (p<0. 01) 
as compared with euthyroid values. We found that carbonyl proteins levels were 
significantly higher (1. 31±0. 33, p=0. 0001) in the serum of Thyroxin treated rats, while in the 
thyroid homogenates, the levels of carbonyl proteins did not differ significantly from the 
control group.  
Thiol groups (SH), superoxide dismutase ( SOD) and reduced glutathione (GSH) were lower 
in the L -thyroxine-administered group in comparison to the control group (p<0. 001).  
A significantly high SH level and a significantly low GSH level were observed in the thyroids 
of the L-thyroxine-administered group in comparison to the control group (p<0. 001).  
We also investigated the relation between the mean values of FT4 and the mean values of 
MDA in the L-thyroxine-administered group. There was a significant positive correlation 
between hyperthyroidism and oxidative stress. (p>0. 5; r2=0. 70).  
Significantly low FT4 (p<0. 001) values were observed in the Propylthiouracil administered 
group as compared with the control group.  
In serum and thyroid tissue of the hypothyroid rats, the MDA levels did not differ 
significantly from euthyroid values (p>0. 05).  
We found that carbonyl proteins levels were significantly higher (0. 99±0. 27, p<0. 05) in 
serum, and the thyroid tissue (1. 99±0. 61, p<0. 05) of the Propylthiouracil treated rats, as 
compared with the control group.  
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Vitamin E supplementation increased significantly the carbonyl proteins levels as compared 
with the hypothyroid rats.  
Thiol groups (SH), superoxide dismutase (SOD) and reduced glutathione (GSH) levels in the 
hypothyroid group did not differ significantly from the control group.  
Administration of Vitamin E to hypothyroid rats resulted in a significant decrease in serum 
antioxidant status parameters (SH, SOD, GSH) levels as compared with the Propylthiouracil 
treated rats.  
Thyroid hormones, of which T3 is the major active form, exert a multitude of physiological 
effects affecting growth, development and metabolism of vertebrates [88], so that they can 
be considered major regulators of their homeostasis. On the other hand, elevated circulating 
levels of thyroid hormones are associated with modifications in the whole organism (weight 
loss and increased metabolism and temperature) and in several body regions. Indeed, low 
plasma lipid levels, tachycardia, atrial arrhythmias, heart failure, muscle weakness and 
wasting are commonly found in hyperthyroid animals. Plasma membrane [89], endoplasmic 
reticulum [90] and mitochondria [91] have been considered as potential cellular sites of 
action of thyroid hormone. However, it is now generally accepted that most of the actions of 
thyroid hormone results from influences on trascription of T3-responsive genes, which are 
mediated through nuclear thyroid hormone receptors [92]. It is worth noting that the idea 
that oxidative stress underlies dysfunctions produced by hyperthyroidism is not in 
contradiction with mediation of T3 action through nuclear events. Indeed, it is conceivable 
that some of the biochemical changes favouring the establishment of the oxidative stress 
(increase in mitochondrial levels of electron carriers, NOS activity and the unsaturation 
degree of lipids) are due to stimulation of the expression of specific genes initiated through 
T3 binding to nuclear receptors. Thyroid hormone induces upregulation of NOS gene 
expression in rat hypothalamus [93], and it is conceivable that this also happens in other 
tissues in which T3-induced NO overproduction has been shown [94, 95, 96].  
The superoxide anion, hydrogen peroxide and the hydroxyl radical are the major reactive 
oxygen species in our body. Free radicals are produced as a consequence of normal 
metabolism and their levels and activities are controlled by enzymatic defense mechanisms, 
such as the SOD, GPx and CAT, and nonenzymatic defense mechanisms, such as ascorbic 
acid, Vitamin E, and GSH [97,98,99]. Oxidative damage arises when an imbalance occurs in 
this system, i. e. over-production of free radicals and/or a decrease in antioxidant defence 
mechanisms [100].  
Disturbances of the oxidant/antioxidant balance resulting from the increased production of 
ROS are causative factors in the oxidative damage of cellular structures and molecules, such 
as lipids, proteins and nucleic acids [101]. In particular, biological membranes rich in 
unsaturated fatty acids are cellular structures susceptible to free radical attack [102].  
Among the mediators involved in the pathophysiology of hyperthyroidism and subsequent 
tissue injury in animal models, free radical-mediated lipid peroxidation plays a pivotal role. 
Oxygen free radicals react with all biological substances. Lipid peroxidation is an 
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autocatalytic mechanism leading to oxidative destruction of cellular membranes. Such 
destruction can lead to cell death and to the production of toxic and reactive aldehyde 
metabolites called free radicals [103]. Lipid peroxidation is associated with a wide variety of 
toxic effects, including decreased membrane fluidity and function, impaired functions of the 
mitochondria and Golgi apparatus and inhibition of enzymes. Malondialdehyde (MDA) is 
an end-product of lipid peroxidation and is frequently measured as an index of these 
processes [104].  
Thyroid stimulating hormone (TSH) affect metabolism and may be affected by the thyroxine 
secretions. High concentrations of thyroid hormones stimulate free radical formation in 
mitochondria by affecting oxygen metabolism [18]. Although reactive oxygen species play 
an important role in physiological mechanisms, extremely reactive oxygen radicals can 
cause severe oxidative damage to molecules [110]. If cellular mechanisms cannot scavenge 
these reactive oxygen species, toxicity is found in biomembranes and lipid peroxidation 
occurs. This damage is usually more evident in cellular membranes.  
Triiodothyronine (T3) and thyroxin (T4) circulating hormones are involved in the modulation 
of the physiological mitochondrial respiration process [105]. These agents were reported to 
change the number and activity of the mitochondrial respiratory chain components. The up 
regulating of these hormones can result in a mitochondrial respiration perturbation and a 
consequent increase in ROS generation [107]. These ROS would lead to oxidative damage to 
biological macromolecules, including lipids, proteins and DNA [108]. In contrast, in the case 
of hypothyroidism, there is a suppression of the metabolic rate and decline in ROS release 
[109].  
Recently, increasing experimental and clinical studies have shown that free radicals play a 
key role in the etiology of many diseases. Thyroid hormones cause oxidative stress as they 
increase ROS, while activating metabolic systems of the body in general. [10] 
Effects of thyroid hormones on lipid peroxidation have been subject of investigation in 
several laboratories but the results are rather contradictory. It was reported that 
hypermetabolic condition in hyperthyroidism was associated with an increase in free radical 
formation and lipid peroxidation levels [10, 11,110]. In previous studies, there are conflicting 
results about oxidative stress in hyperthyroidism. In some studies, it was demonstrated that 
the products of lipid peroxidation were decreased [111,112]. On the contrary, Fernandez et 
al. [10] and Dumitriu et al. [113] found high products of lipid peroxidation. Similarly, 
Iangalenko et al. [114] found that lipid peroxidation was increased in hyperthyroid patients. 
Asayama et al. [115] showed that the damaging effect of lipid peroxidation was increased in 
liver, heart and some skeletal muscles of rats, diminishing antioxidant enzymes in 
experimental hyperthyroidism.  
Peroxidative effects elicited by thyroid hormones were found in the brain of newborn [116] 
and adult [117] rats. Such effects were also found in heart homogenates [110, 11, 118, 119] 
from young rats. However, increased lipid peroxidation in hearts from old (1. 5 years) but 
not from young (8 weeks) hyperthyroid rats was also reported [120]. Thyroid hormone 
treatment was found to increase lipid peroxidation in lymphoid organs such as mesenteric 
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lymph nodes and thymus, without major effects in the spleen [12], a thyroid hormone-
unresponsive tissue [121]. Thus, no significant change (TBARS) or decrease (HPs) were 
observed in lipid peroxidation level in the testis from adult hyperthyroid rats [122], and the 
thyroid hormone-induced increase in lipid peroxidation was found to be confined to some 
skeletal muscles. In both rat [11, 12] and cat [123], such an increase was found in the soleus, a 
red muscle mainly composed of slow-twitch oxidative glycolitic fibres (type I). Conversely, no 
change was found in the extensor digitorum longus (EDL) [11, 123], a white muscle mainly 
composed of fast-twitch glycolitic fibres (Type IIb). These results are consistent with early 
observations that red, but not white muscles, are sensitive to thyroid hormones [124, 125]. 
Lipid peroxidation was also increased by thyroid hormone in rat gastrocnemious [110,126], a 
mixed fibre muscle also containing fast-twitch oxidative glycolytic fibers (type IIa), but was 
decreased in the white portion of such a muscle [12]. On the other hand, it is surprising that in 
kidney from hyperthyroid rats the lipid peroxidation level does not change [127], although the 
tissue exhibits a calorigenic response to thyroid hormone similar to that elicited in liver [121].  
Studies on the mouse showed lower susceptibility to thyroid hormone-induced lipid 
oxidative damage. Indeed, levels of lipid peroxidation were found to be increased in 
hindlimb muscles [128], unchanged in heart [129] and decreased in liver [107] from 
hyperthyroid mice. The results concerning liver were attributed by the authors to the animal 
species or long-term (4-5 weeks) treatment they used, because a laboratory study describing 
no increase in index of lipid peroxidation in hyperthyroid rat liver used the same long-term 
treatment [11]. Although this may be true, it is interesting that in both mouse and rat 
hyperthyroidism was induced by T4, whose biological activity can differ from T3 in some 
tissues. Indeed, recent studies have shown that T4, but not T3, increases lipid peroxidation 
in rat interscapular brown adipose tissue [130].  
Although the pathophysiological consequences of the accelerated lipid peroxidation are not 
yet fully elucidated, this biochemical change is thought to be responsible for some 
complications of hyperthyroidism. However, it is still to be determined whether the various 
target tissues of thyroid hormone undergo other biochemical changes that either predispose 
to free radical-mediated injury, or oppose it.  
Despite some contradictory reports, the aforementioned results provide strong evidence that 
thyroid hormones induce oxidative stress in target tissues. Oxidative stress results from a 
disturbance of the normal cell balance between production of ROS and the capacity to 
neutralize their action.  
In aerobic cells O2 is mainly consumed through its four-electron reduction to water by 
cytochrome c oxidase. This reaction occurs without release of any intermediate in the O2 
reduction. However, despite the efficiency of the mitochondrial electron transport system, 
the nature of the alternating one-electron oxidation-reduction reactions it catalyses 
predisposes electron carriers to side reactions, in which an electron is transferred to O2 
directly, instead of the next electron carrier in the chain, generating O2 [131]. This radical is 
then converted by spontaneous or catalysed dismutation into hydrogen peroxide (H2O2) 
[132], which can be turned into highly reactive hydroxyl radical (OH).  
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Numerous oxidases in the cytosol, endoplasmic reticulum and outer mitochondrial 
membrane also contribute to O2 consumption and lead to O2 and H2O2 generation [133].  
Major complications of hyperthyroidism are the myopathy and cardiothyreosis [81].  
Joanta et al. [134] revealed an increase of the lipid peroxides content and carbonyl proteins 
level in blood, liver, thyroid, heart and skeletal muscle in experimental hyperthyroidism, 
suggesting that thyroid hyperfunction is accompanied by oxidative stress. R. Shinohara et 
al. [120] have investigated how thyroid function might influence the production of oxygen 
free radicals, the lipid peroxidation process and antioxidant activity in muscle of rat 
myocardium. It was found that the degree of lipid peroxidation, assessed by measuring 
substances that react with thiobarbituric acid, significantly increases in animals with 
hyperthyroidism than euthyroidiene.  
Also the antioxidant enzyme activity changed: increased the xanthine oxidase and 
superoxiddismutase and decreased the glutathione peroxidase. These changes in the 
prooxidant/antioxidant balance, caused by thyroid hormones excess could be involved in 
myocardial dysfunction.  
Zaiton et al. [123] revealed increased concentration of lipid peroxidation products in the 
myocardium and solear muscle in rat, but not in liver tissue. Conflicting results obtained 
Fernandez et al. [10] : increased liver content in lipid peroxides induced by thyroid 
hormones. Tapia et al. [135] studied the influence of thyroid hormones on Kupffer cells 
activity in isolated liver, perfused with colloidal carbon solution. The conclusion was that 
hyperthyroidism increase Kupffer cells activity and the production of oxygen free radicals at 
this level. Therefore liver macrophages could be an alternative source of reactive species.  
Retroocular fibroblast proliferation is involved in the pathogenesis of ophthalmopathy in 
Basedow-Graves disease. H. Burch et al. [136] studied the way in which the superoxide radical, 
generated by the xanthine oxidase/hypoxanthine system, can induce cell proliferation in 
fibroblast cultures from patients with severe ophthalmopathy, as well as from control patients, 
in whom the excision of retroorbital tissue was performed. The authors found that the 
superoxide radical determined fibroblast proliferation, the intensity of this phenomenon 
depending on the concentration of reactive oxygen species. The effectiveness of some 
pharmacological agents on retroocular fibroblast proliferation induced by the superoxide 
radical was also monitored. For this, retroocular tissue was incubated with methimazole, 
propylthiouracil (synthesis antithyroid drugs), allopurinol (a xanthine oxidase inhibitor), and 
nicotinamide (an antioxidant). The most effective regarding the inhibition of superoxide 
radical production and implicitly, that of fibroblast proliferation, were methimazole, 
allopurinol and nicotinamide. These results suggest the implication of reactive oxygen species 
in retroocular fibroblast proliferation in Basedow-Graves disease [137].  
Mitochondria are particularly susceptible to ROS-induced damage because they are a major 
site of oxygen free radical production [138] and contain great amounts of high and low 
molecular weight Fe2+ complexes, which promote the oxidative damage of membrane lipids 
[139,140]. Thyroid state-linked changes in the balance between ROS production and 
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antioxidant capacity should result in changes in the damage to mitochondrial components. 
Therefore, we investigated the effects of altered thyroid states on the extent of oxidative 
damage of mitochondrial lipids and proteins.  
It is well known that MDA is a terminal product of lipid peroxidation. So the content of 
MDA can be used to estimate the extent of lipid peroxidation. The latter can indirectly 
reflect the status of the metabolism of free radicals, the degree to which the tissue cells are 
attacked by free radicals and the degree to which lipid is peroxidated.  
In our study in the plasma of L-thyroxine-treated rats, the marker of lipid peroxidation 
(MDA) levels did not differ significantly from the euthyroid values. This result of 
unchanged lipid peroxidation level can be correlated with the observations of Asayama et 
al. [11] who found no change of MDA in liver homogenates from hyperthyroidism induced 
rats rendered hyperthyroid by administration of T4 to their drinking water over a 4-week 
period. However our results are not in concordance with the findings of Seven et al. [141] 
who found a significant increase in MDA levels in the plasma of rats rendered hyperthyroid 
by administration of T4 in their food for 24 days and Venditti et al. [110] who noticed that 
hyperthyroidism induced in rats by T3 daily i. p. injections for 10 days caused significantly 
increased MDA levels in liver, heart and skeletal muscle homogenates.  
These discrepancies among results seem to reflect a dependence of peroxidative processes 
on various factors, such as tissue, species, the iodothyronine used and treatment duration. 
On the other hand, it is not possible to exclude the fact that some conflicting results depend 
on the different accuracies of the methods used for lipid peroxidation determination. For 
example the method for evaluating thiobarbituric acid reactive substances (TBARS) is 
inaccurate, and returns results which differ according to the assay conditions used [19].  
The high increase in the level of MDA and hydroperoxides in hyperthyroidism might be 
due to the possible changes in the cellular respiration of target tissues, which are 
undoubtedly related to any alteration in the thyroid function, knowing the major role of the 
thyroid hormones in the control (acceleration) of the mitochondrial respiration rate [108], [2] 
and [28]. From a biochemical point of view, the provoked hyperthyroidism, and via a 
variety of mechanisms, mitochondrial respiratory chain activity is altered, leading to an 
increase in electrons transfer from the respiratory chain through the acceleration of the 
cellular metabolism rate, resulting in the increased generation of superoxide (O2−) at the site 
of ubiquinone [7]. Superoxide radicals can lead to the formation of many other reactive 
species, including hydroxyl radicals (OH), which can readily start the free-radical process 
of lipid peroxidation [3] and [6].  
Proteins are also sensitive to oxidative damage which leads to alteration in their structure 
and ability to function [142]. Protein oxidation can lead to a loss of critical thiol groups (SH) 
in addition to modifications of amino acids leading to the formation of carbonyl and other 
oxidized moieties[143,144,145].  
Oxidative cleavage of proteins by either the alpha-amidation pathway or by oxidation of 
glutamyl side chains leads to formation of a peptide in which the N-terminal amino acid is 
blocked by an alpha-ketoacyl derivative. However, direct oxidation of lysine, arginine, 
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proline and threonine residues may also yield carbonyl derivatives. In addition, carbonyl 
groups may be introduced into proteins by reactions with aldehydes (4- hydroxi-2- nonenal, 
malondialdehyde) produced during lipid peroxidation or with reactive carbonyl 
derivatives( ketoamine, ketoaldehydes, deoxyosones) generated as a consequence of the 
reaction of reducing sugars or their oxidation products with lysine residues of proteins 
(glycation and glycoxidation reactions). The presence of carbonyl groups in proteins has 
therefore been used as a marker of ROS-mediated protein oxidation [134].  
There are not many data regarding the effect of the thyroid state on protein oxidation. In 
experimental hyperthyroidism increased protein oxidation was demonstrated in different 
tissues [146,147]. Enhanced myocardial protein oxidation was also shown in the study of 
[148] by means of carbonyl group measurement. An elevation of this protein oxidation 
marker was demonstrated in the plasma of hyperthyroid patients [149,147].  
In our study, the increased levels of protein-bound carbonyls in serum of L-thyroxine-
treated rats is in agreement with the earlier reports [150,151] suggesting the role of free 
radicals in the pathogenesis, which demand the need for studies assessing the therapeutic 
role of antioxidants in hyperthyroidism.  
A recent study[152] found a positive association between thyroid hormones in excess and 
lipid peroxides correlated by linear regression which clearly suggest induction of oxidative 
stress. Such an effect may be related to the enhanced metabolic rate generated by thyroid 
hormone administration, leading to an accelerated ROS production [153,141].  
In the thyroid homogenates of the L-thyroxine administered rats, the MDA values were 
significantly decreased and carbonyl proteins levels did not show significant changes.  
These results show that hyperthyroid state is not accompanied by oxidative stress in the 
thyroid gland and contradict the results of [134] who observed an increase in lipid peroxides 
and carbonyl proteins in the same tissue in experimental hyperthyroidism.  
The synthesis of thyroid hormones crucially depends on H2O2, which works as a donor of 
oxidative equivalents for thyroperoxidase [154]. Because of its great toxicity, H2O2 synthesis 
must always remain in adequation with the hormonal synthesis and strictly contained at the 
apical pole of the cell. Thyrocytes possess various enzymatic systems, such as GPx, catalase, 
superoxide dismutases, and peroxiredoxins that contribute to limit cellular injuries when 
H2O2 or other ROS are produced in excess [155,156,157].  
Our findings may be explained by the fact that the external administration of thyroid 
hormones usually inhibits pituitary secretion of TSH and indirectly hormonal synthesis 
[158]. It is therefore possible that decreased oxidative stress observed in thyrocytes, is due in 
part to the absence of H2O2.  
6. Antioxidant status 
Substances that neutralize the potential ill effects of free radicals are generally grouped in 
the so-called antioxidant defence system. Such a system includes both low molecular weight 
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free-radical scavengers and a complex enzyme array involved in scavenging free radicals, 
terminating chain reactions, and removing or repairing damaged cell constituents. To 
provide maximum protection, these substances are strategically compartmentalized in 
subcellular organelles within the cell and act in concert. In examining antioxidant changes 
found in hyperthyroid tissues, it needs to be underscored that although thyroid hormone 
can directly control levels of enzymes with antioxidant activity or regulate scavenger 
content, antioxidant depletion could not be the cause, but the consequence of the oxidative 
stress. The effects of thyroid hormone on antioxidant status have been extensively 
investigated in rat tissues, while a few data concerning other species are available [159].  
Several antioxidant enzymes exist that convert ROS into less noxious compounds, for 
example, superoxide dismutase (SOD), catalase, thioredoxin reductase, peroxiredoxin and 
glutathione peroxidase (GPx) [160,161,162,163,164]. Collectively, these enzymes provide a 
first line of defense against superoxide and hydrogen peroxides. They are of enormous 
importance in limiting ROS-mediated damages to biological macromolecules, but they are 
not able to be 100% effective because certain compounds generated by the interaction of 
ROS with macromolecules are highly reactive. It is then mandatory to detoxify these 
secondary products in order to prevent further intracellular damage, degradation of cell 
components and eventual cell death. This second line of defense against ROS is provided by 
enzymes such as GPx, glutathione S-transferase (GST), aldo-keto reductase and aldheyde 
dehydrogenase [165,166,167]. Thus, the central role of reduced GSH appears clear in 
intracellular endogenous antioxidant defenses as it is involved in all the lines of protection 
against ROS [35].  
The tripeptide γ-glutamylcysteinylglycine or GSH is the major nonenzymatic regulator of 
intracellular redox homeostasis, ubiquitously present in all cell types at millimolar 
concentration [168]. This cysteine-containing tripeptide exists either in reduced (GSH) or 
oxidized (GSSG) form, better referred to as glutathione disulfide, and participates in redox 
reactions by the reversible oxidation of its active thiol [169]. Under normal cellular redox 
conditions, the major portion of this regulator is in its reduced form and is distributed in 
nucleus, endoplasmic reticulum and mitochondria. In addition, GSH may be covalently 
bound to proteins through a process called glutathionylation and acts as a coenzyme of 
numerous enzymes involved in cell defense [170]. Glutathione can thus directly scavenge 
free radicals or act as a substrate for GPx and GST during the detoxification of hydrogen 
peroxide, lipid hydroperoxides and electrophilic compounds. Glutathione peroxidases 
constitute a family of enzymes, which are capable of reducing a variety of organic and 
inorganic hydroperoxides to the corresponding hydroxy compounds, utilizing GSH and/or 
other reducing equivalents. There are several tissue-specific GPx's that exhibit also tissue-
specific functions [171]. All of them are selenoproteins and their primary function is to 
counteract oxidative attack. During the catalytic cycle, selenium is oxidized by the 
hydroperoxide to a selenic acid derivative. This intermediate is subsequently reduced by the 
electron donor. When GSH is used, a seleno-disulfide is formed, which is cleaved by a 
second GSH molecule to yield the reduced GPx. During catalysis the oxidation state of the 
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enzyme depends on the relative concentration of the reducing (GSH) and oxidized 
(hydroperoxides) substrates. The phospholipid hydroperoxide GPx — discovered as a factor 
preventing lipid peroxidation — is considered to be involved in the protection of 
biomembranes against oxidative stress. In general, these isoenzymes may have a role in the 
regulation of the delicate regional redox balance, in particular the regulation of the 
appropriate tone of hydroperoxides known to be involved in cellular signaling, and to evoke 
several cellular responses, for example, programmed cell death, proliferation, cytokine 
production, and so on [172]. Glutathione S-transferases are three enzyme families — 
cytosolic, mitochondrial and microsomal — that detoxify noxious electrophilic xenobiotics, 
such as chemical carcinogens, environmental pollutants and antitumor agents. Moreover, 
they protect against reactive compounds produced in vivo during oxidative stress by 
inactivating endogenous unsaturated aldehydes, quinones, epoxides and hydroperoxides, 
all of which are produced intracellularly after the exposure to pollutants, or consumption of 
overcooked or mycotoxin-contaminated food, or polluted water [173]. Glutathione S-
transferases exert those protective effects because they are able to catalyze the conjugation of 
GSH with oxidation end products and represent a second line of defense against the highly 
toxic spectrum of substances produced by ROS-mediated reaction. Both GPx and GST 
activities can eventually lower the level of total intracellular GSH. During the course of the 
reaction catalyzed by GPx, the exaggerated production of GSSG can lead to the formation of 
mixed disulfides in cellular proteins, or to the release of GSSG excess by the cell, to maintain 
the intracellular GSH/GSSG ratio. During the GST-mediated reactions, GSH is conjugated 
with various electrophiles and the GSH adducts are actively secreted by the cell. Mixed 
disulfide formation together with GSSG or GS-conjugated efflux can result in the depletion 
of cellular GSH, which can be opposed by a de novo synthesis or by reducing the formed 
GSSG. In the presence of oxidative stress, GSH concentration rapidly decreases while GSSG 
— potentially highly cytotoxic — increases because of the reduction of peroxides or as a 
result of free radical scavenging. This has two important consequences: (1) the thiol redox 
status of the cell will shift and activate certain oxidant response transcriptional elements, 
and (2) GSSG may be preferentially secreted from the cell and degraded extracellularly, 
increasing the cellular requirement for de novo GSH synthesis. Glutathione disulfide can 
also be reduced back to GSH by the action of glutathione reductase (GRed) utilizing 
NADPH as a reductant [174]. Glutathione reductase is a flavoenzyme and is represented by 
a single-copy gene in humans. It has been observed that exposure to agents that lead to 
increased oxidative stress also leads to an increase in its mRNA content. Further 
experimental data have shown the importance of GRed activity in GSH metabolism, 
demonstrating that the enzymatic activity is regulated in response to stress, and that 
mutations affecting GRed activity would have deleterious consequences. The recycling 
pathway for GSH formation is thus fundamental in the metabolism of GSH-dependent 
defense reactions [175]. In conclusion, the presence of GSH is essential, but not in itself 
sufficient, to prevent the cytotoxicity of ROS, being of fundamental importance the 
functionality of the glutathione-dependent enzymes, which participate in the first and 
second lines of defense.  
 Antioxidant Enzyme  214 
Thyroid hormones increase oxygen consumption via a thermogenetic effect. In 
hyperthyroidism caused by thyroxine or triiodothyronine administration, the increase in 
metabolic rate together with the increase in oxygen consumption enhances microsomal 
oxidative capacity and free radical formation. There are conflicting results about an increase 
or decrease in the activities of antioxidant enzymes in hyperthyroidism [12, 16; 176-182]. In 
some studies, it has been reported that SOD activity was significantly increased [12,179,181]. 
On the contrary, several authors reported that SOD activity were reduced in patients with 
hyperthyroidism [180,182].  
Superoxide dismutase is an important intracellular oxygen radical-scavenging enzyme. It 
has been demonstrated that hyperthyroidism leads to accelerated free radical formation 
[183]. Conversely, increased free radical formation enhances intracellular scavenging 
enzymes, like SOD, in experimentally induced hyperthyroidism [141].  
Regarding the way in which thyroid gland hyperfunction influences antioxidant defense 
capacity, the results are different from one study to another. The organism can defend itself 
against the effects of oxidative stress by increasing SOD activity as a protection mechanism, 
but we observed a decreased SOD activity in our study. The observed diminution of SOD 
activity in rats, following L-thyroxine treatment can be correlated with the observations of 
[184]. However, our results are not in good agreement with the findings of [141] and [185], 
who noticed that hyperthyroidism induced in rats by T3 caused an elevation of SOD activity 
in liver. Such a discrepancy between our and their results may be due to different 
experimental conditions and different methods used to assay SOD activities.  
There is no difference in SOD activity between hyperthyroid patients and controls or 
between hypothyroid patients and controls in the studies of both [6] and [186]. Effects of 
thyroid hormones on SOD activity have been evaluated by others, but results are rather 
contradictory. The increase of SOD has been shown in the blood of patients with 
hyperthyroidism [6]. On the contrary, Erdamar et al. [187] found decreased SOD activity in 
the blood samples of patients with hyperthyroidism.  
Varying forms of SOD (Mn-SOD, CuZn-SOD) present in the thyroid are the first line of 
defense in neutralizing ROS [188]. One study correlates several thyroid disorders to levels of 
CuZn-SOD and Mn-SOD, which are very high in malignant tumors [189]. This is a natural 
occurrence in the body to prevent and eliminate excess ROS that might result from, or have 
caused, these diseases. Therefore, SOD in the thyroid may involve two roles: (i) to serve as 
an antioxidant enzyme to protect the thyroid from oxidative stress, and (ii) to provide H2O2 
for hormone synthesis [190].  
There are two types of SOD enzymes reported in higher vertebrates. One is Cu-Zn SOD, 
mainly found in the cytoplasm of cells, while the other one is mitochondrial in nature and is 
known as Mn-SOD[191,192]. Mn–SOD activity in cardiac tissue was reported to both 
increase [11,120,179] and remain unchanged [118,193], even though in all cases 
hyperthyroidism was elicited by long-term treatment with T4. Mn–SOD was also found to 
increase in the soleus and white portion of gastrocnemious muscle from rats made 
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hyperthyroid by combined T3 and T4 administration [12] and in soleus[11] and 
gastrocnemious [194] from T4- treated rats.  
Cu-Zn SOD activity increased in gastrocnemious [194] and in its white portion [12], in 
agreement with insensitivity of such muscle to thyroid hormone, whereas it was reported to 
both decrease [179] and remain unchanged [11,120] in cardiac muscle, despite the same 
prolonged treatment with T4. Total SOD was found to decrease in liver [180] and increase in 
heart from young [120,157] but not from old [120] hyperthyroid rats.  
The increase in SOD activity in hyperthyroidism indicates the presence of oxidative stress 
due to the increasing mitochondrial oxidation rate, characterised by an overproduction of 
superoxide anion. The latter is known for its harmfulness to the cell membrane. The SOD is 
also known for its role in transforming O2− into inorganic hydroperoxide (H2O2), which 
will, in turn, be reduced by both CAT and GPx enzymes [108], [120] and [195]. Accordingly, 
an increase in CAT activity in the homogenates of hyperthyroid rats is noted. This 
accelerates the speed of the formation of superoxides and the renewal of H2O2 quantity 
(substrate of CAT), which increases CAT activity until the dismutation of hydrogen 
peroxide [196], [197] and [147]. Both SOD and CAT function together in a way linked to the 
dissociation and formation of H2O2, and their activities are adjusted by their variation in the 
thyroid gland's activity.  
One enzyme activity leads to the formation of a substrate for another one, whereby the 
excess of hydrogen peroxide may serve as a factor of SOD inactivation. On the other hand, 
GPx may be inactivated by the superoxide radical excess. Thus, GPx is protected from its 
inactivation via superoxide radical just by the enhanced SOD activity [198]. Based on such a 
sequence of events,it has been postulated that hyperthyroidism might be accompanied by 
the induction of either SOD or GPx or both [140].  
For catalase (CAT) activity an increase in the white portion of gastrocnemious [12] and both 
decrease [11] and increase [12] were found in soleus from hyperthyroid rats. Decreases in 
CAT activities were found in brown adipose tissue after T3 or T4 treatment [130] and in liver 
[11,16], whereas lack of change [120,156, 179] and decrease [11] were found in heart.  
The relationship between hyperthyroidism and glutathione peroxidase (GPX) activity also 
appears not well defined. Indeed, it was reported that cardiac activity decreased after long-
term T4 treatment of both young [11, 156] and old [120] rats, increased [118] and remained 
unchanged [120] after long-term T4 treatment of young rats, and remained unchanged after 
short-term T3 treatment of young rats [110]. Liver GPX activity was found to decrease after 
T4 treatment [11], but both increased [16] and remain unchanged [110,199] after T3 
treatment.  
Moreover, it was found that T3 treatment increased GPX activity in gastrocnemious [110], 
while T4 and T3+T4 treatments decreased such activity in gastrocnemious [194] and in its 
white portion [12], respectively. T4 administration also decreased GPX activity in both 
thyroid hormone responsive (soleus) [11] and unresponsive (EDL) [11] muscles. Enzyme 
activity was found increased in brain from hyperthyroid newborn rats [116].  
 Antioxidant Enzyme  216 
The changes induced by T3 treatment in both liver [16,110,199] and heart [110], but not in 
muscle glutathione reductase (GR) activities shown in the various laboratories were 
consistent with those found for GPX activities. It is interesting that in brain of newborn 
hyperthyroid rats the activities of antioxidant enzymes (Cu, Zn,-SOD, CAT and GPX) 
exhibited compensatory increase that did not prevent oxidative stress [116].  
Joanta [200] evidenced an increase in the concentrations of total peroxidase and catalase in 
the liver, thyroid, brain and blood, a decrease in the activity of these enzymes in the 
myocardium and skeletal muscle. This does not only confirm the main role of the thyroid 
hormones in regulating the oxidative stress in target cells, but is also in agreement with that 
of [16]and[6], where an icrease in GPx activity in hyperthyroid rats was observed. In 
contrast, Asayama et al. [11] found a low glutathione peroxidase concentration in the liver 
tissue taken from rats with experimental hyperthyroidism. These differences have multiple 
causes. An explanation could be related to the amount of thyroid hormones administered to 
the animals. Asayama et al. [11] administered thyroxine in a dose of 0. 0012% in the drinking 
water, Morini et al. [16] 30 μg T3/100 g body weight/day and Venditti et al. [110] 10 μg T3/100 
g body weight/day to the rats previously treated with methimazole. The difference in GPx 
enzyme activity was probably due to the age (eight weeks) of the rats used in the 
investigation of [6]. The physiological state of the thyroid gland, the dose and the duration 
of treatment are also of a major influence on antioxidant enzymes. It was reported in 
previous studies that the level of lipid peroxidation in the heart was affected by both the age 
and the state of the thyroid gland, in hyperthyroid rats [120]. From another point of view, 
the above-mentioned effects might involve an accumulation of superoxide anion that 
inhibits CAT activity, giving rise to hydrogen peroxide (H2O2) concentrations [108].  
Another explanation could be that at cellular level, there are other antioxidant systems [201], 
whose activity has not been evaluated by the mentioned investigations.  
The decrease in GPx activity could in part be ascriebed to the fact that it is a selenoenzyme-
like D1(5′-deiodinase I),which is involved in T4 transformation into active T3. As the 
enhanced hormone production is very pronounced in hyperthyroidism, deiodination of T4 is 
also increased. Since the body stores of selenium are limited, deiodination is given 
preference over GPx in selenium supply. In 1994, Köhrle described GPx as a sort of selenium 
store easily available for D1 activity [202]. Other selenoproteins such as selenoprotein P 
mediate the transfer of selenium between the two enzymes. Thus, selenium deficit might be 
the cause of reduced GPx activity [203].  
Function of intracellular GPx is degradation of H2O2 and hydroperoxides of free fatty acids, 
whereas in plasma GPx catalyses degradation of H2O2 and hydroperoxides of 
phospholipids. In addition GPx exert a protective effect on membrane phospholipids by 
inhibiting their peroxidation processes [204]. According to hypothesis proposed by Seven et 
al. increased ROS production may lead to elevated GPx activity [205]. Because of the fact 
that proteins are not synthesized de novo in erythrocytes, it can be suspected that these cells 
contain high reserves of enzymatic protein levels; therefore on one hand it is possible to 
activate antioxidant enzymes in response to ROS activity, and on the other hand- correction 
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of losses caused by oxidative stress. Reduction of antioxidant potential of red blood cells 
occurring in thyrotoxicosis is explained by more rapid degradation of enzymatic proteins 
[206].  
The increase of some antioxidant enzymes activities such as SOD, GPx and CAT, which are 
the main antioxidants in the body may be indicative of the failure of compensating the 
induced oxidative stress [207,208]. These enzymes may scavenge excess O2‾ and H2O2, and 
peroxides ROOH produced by free radicals. For example, SOD catalyzes the conversion of 
superoxide anion radical to H2O2. The resulting hydrogen peroxide in turn is decomposed 
by the enzymes GPx and CAT [209,210]. We suggest that the mentioned alterations are 
given of functional changes induced by radical over-production and an increase in the 
biosynthesis of antioxidant enzymes. Thus, the increase of some antioxidant enzymes 
activities such as SOD, GPx, and CAT may be an indication of the failure of compensating 
the induced oxidative stress. Also, it has been suggested by[140] that free-radical scavenging 
enzyme activity can be induced by excessive formation of ROS in experimental 
hyperthyroidism was previously reported.  
Results of the studies analyzing the indicators of SOD, GPx and catalase enzymes in thyroid 
tissue are quite contradictory [11,12, 211,212]. The discrepancy may be due to variation in 
the samples analyzed, grade of hyperthyroidism, methods of determination and result 
expression (enzyme activity or concentration, expression of enzyme concentration or 
activity per protein or tissue mass).  
Significantly high levels of the SH groups (p=0. 0006) and low levels of GSH (p=0. 0001) 
were found in thyroid homogenates of the L-Thyroxin treated group as compared with the 
control group, reflecting reduced oxidative stress and low antioxidant capacity. Similar 
results were described at the level of expression, by Western blot in a recent paper [213] 
where in T4 treated rats there was a decrease in the level of oxidative stress and in the level 
of GPx.  
Antioxidant status parameters, namely thiol groups (SH), superoxide dismutase (SOD) and 
glutathione (GSH) were significantly decreased in the present study, in the plasma of 
hyperthyroidism-induced rats in comparison to the control group (p<0. 001).  
Glutathione is a tripeptide, γ-L-glutamyl-L-cysteinyl-glycine, and is found in all mammalian 
tissues and it is especially concentrated highly in the liver [214]. GSH is a nucleophilic 
“scavenger” of numerous compounds and their metabolites, and a cofactor in the GPx-
mediated destruction of hydroperoxides, which protects the cell membrane against 
oxidative damage by regulating the redox status of protein in the cell membrane [215,216]. It 
is widely distributed and involved in many biological activities including neutralisation of 
ROS, detoxification of xenobiotics, and maintenance of –SH levels in proteins [108]. In this 
study, we noted important reduction in GSH levels in hyperthyroid rats, which reflects its 
consumption through the oxidative stress. This not only confirms the main role of the 
thyroid hormones in regulating the oxidative stress in target cells, but also is in agreement 
with previous data. GSH depletion, a major hepatic alteration induced by hyperthyroidism 
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in experimental animals [199] and [180] and man [217], is determined by both loss of 
tripepetide into the blood and higher intracellular catabolism, despite the enhancement in the 
rate of GSH synthesis and in the GSH turnover rate triggered in the liver [199,218]. Enhanced 
production of free radicals and the increase of antioxidant enzymes activities have been 
suggested as possible mechanisms to explain hyperthyroid-induced oxidative damage [219].  
The GSH-dependent defence system plays an important role against lipid peroxidation in 
cells. Insufficiency of GSH is one of the primary factors that permits lipid peroxidation. It 
has been reported that GSH plays an important role in the detoxification of hydroperoxides 
and prevents the effect of lipid peroxidation [220]. Therefore, the decreased level of GSH 
may be due to the overproduction of free radicals and increased lipid peroxidation in 
hyperthyroidism [115]. However, lowered blood GSH levels may also be explained by some 
other possibilities, including: (i) an increased oxidation rate; (ii) increased utilization of GSH 
during the removal of lipid and other peroxides; and (iii) decreased glucose-6-phosphate 
dehydrogenase activity, which causes diminished production of GSH.  
In contrast with our results, [140],[16] and [221] have demonstrated increased levels of GSH 
in blood from hyperthyroid rats. Activities of oxygen radical scavenging enzymes are 
expected to increase in response to sustained oxidative stress such as that in 
hyperthyroidism [115]. High levels of GSH in the erythrocytes of hyperthyroid rats are open 
to various interpretations. According to Visser [222], GSH, a required endogenous cofactor 
in the conversion of T4 to T3, is transported in increased amounts from the liver to blood to 
meet the needs of increased peripheral T4- T3 conversion. On the basis of the suggestion by 
Morini et al. [16] that thyroid hormones alter the membrane fluidity, Seven et al [141] 
suppose a change in GSH concentration due to altered transport hyperthyroid state.  
These differences in antioxidant enzyme activity may be caused by various mechanisms. 
The reactive oxygen species contribute to an intensified synthesis of antioxidant enzymes in 
tissues and hence their elevated activity may be a manifestation of adaptation mechanisms 
in response to oxidative stress. A decreased activity of antioxidant enzymes or a decreased 
non-enzymatic antioxidant concentration may be caused by their intensified utilization in 
protection against oxidative tissue damage [181, 223]. There are a number of factors that 
may influence antioxidant system activity: the physiological state of the thyroid gland, the 
dose and the duration of treatment. In experimental studies, antioxidant enzyme activity 
was affected by the age of the animals with induced hyperthyroidism[120].  
The great majority of the energy released under basal conditions is used by the cell for the 
maintenance of the Na+-K+ dependent ATP-ase activity. Thyroid hormones enhance the 
function of this pump by intensifying its activity at cellular level. This increased use of ATP 
associated with the intensification of oxygen consumption by the oxidative phosphorylation 
pathway generates reactive oxygen species [224].  
At the level of the thyroid follicular cell, inorganic iodine, introduced in the body through 
diet, is oxidized to the iodinium ion (I+), extremely reactive, which will bind to tyrosine 
residues from the structure of thyroglobulin. Iodine is oxidized by an enzymatic complex 
termed thyroperoxidase (TPO), which requires the presence of oxygenated water (H2O2) as 
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an oxidizing agent. Further on, the process of oxidative condensation of iodotyrosines also 
involves thyroperoxidase (TPO) and oxygenated water (H2O2). Although the exact 
mechanism of the generation of oxygenated water (H2O2) is uncertain, it is supposed that 
NADPH-dependent cytochrome c reductase is involved in the intrafollicular generation of 
oxygenated water (H2O2) [225].  
Under normal conditions, TSH stimulates the organification of iodine by the increase in the 
production of oxygenated water (H2O2). In hyperthyroidism, TSH anti-receptor antibodies 
induce a sustained and continuous secretion of thyroid hormones. The higher the synthesis 
of thyroid hormones, the higher the production of oxygenated water (H2O2) in the thyroid 
follicle [9].  
The activity of some hepatic enzymes, such as NADPH-cytochrome P-450 reductase, is 
regulated by thyroid hormones. So, the excess of thyroid hormones followed by the 
intensification of the cytochrome P-450 reductase activity is responsible for the increased 
production of superoxide and hydroperoxide anion at hepatic level [108].  
On the other hand, hypothyroidism is a disease because of a diminished thyroid hormone 
synthesis, resulting from thyroid gland dysfunction. Physiologic alterations generally occur 
because of the hypometabolic state induced by hypothyroidism [226].  
The depression of basal metabolism is associated with decreased mitochondrial oxygen 
consumption and less ROS generation, resulting in decreased lipid peroxidation and protein 
oxidation [210].  
Recent studies have shown an increased production of reactive oxygen species in 
hypothyroidism. There is disagreement on the effect of hypothyroidism on tissue oxidative 
stress. While Pereira et al. [12] suggested that hypothyroidism tended to diminish lipid 
peroxidation in lymphoid organs, Dumitriu et al. [113] observed the high levels of blood lipid 
peroxidation in hypothyroidism. It has been also reported that antioxidant enzyme levels are 
decreased in hypothyroid stage. These different results were explained in terms of tissue 
variation in haemoprotein content and/or of antioxidant capacity by Venditti et al. [110].  
Hypothyroidism is known to induce metabolic suppression and lower respiration rate, and 
reduction of free-radical formation, accompanied by a fall in peroxide levels [112]. Our results 
show a general lack of significant changes in levels of lipid peroxidation (MDA) in serum and 
thyroid tissue of hypothyroid rats. This is in line with the results of Venditti et al. [110] who 
showed that in all tissues of hypothyroid rats, the malondialdehyde (MDA) levels did not 
differ significantly from euthyroid values. Mano et al. [15] found that the concentration of lipid 
peroxides, determined indirectly by the measurement of thiobarbituric acid reactants, did not 
change in hypothyroid rats when compared with the euthyroid animals. Dariyerli et al. [227] 
showed that there is no statistically significant difference found between hypothyroid and 
control groups in the lipid peroxidation indicator MDA. The results of Yilmaz et al. [228] who 
reported increased plasma, liver and muscle MDA levels in hypothyroid rats contradict our 
findings. Sarandol et al. [229] observed increased lipid peroxidation in plasma, liver, heart and 
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muscle of Propylthiouracil treated rats reflecting an enhanced oxidative status in 
hypothyroidism. On the other hand, Venditti et al. [210] reported significantly decreased levels 
of hydroperoxides and protein-bound carbonyls in hypothyroid tissues.  
This conflicting findings are thought to be due to different study materials in several animal 
models [110].  
In our study we found that carbonyl proteins levels were significantly increased in serum, 
and the thyroid tissue of the Propylthiouracil treated rats, suggesting the presence of 
oxidative stress in hypothyroidism. This is in agreement with Nanda et al. [230] who found 
significantly higher carbonyl proteins levels in plasma of hypothyroid patients compared to 
their respective controls.  
The mechanism of increased oxidative stress in hypothyroidism is controversial. Although 
most of the studies did not suggest it, an insufficient antioxidant defence system is thought 
to be a factor.  
Antioxidant status parameters, namely thiol groups (SH), superoxide dismutase ( SOD) and 
reduced glutathione (GSH) levels did not differ significantly in serum, and the thyroid 
tissue of the hypothyroidism-induced rats in comparison to the control group.  
GSH is endogenously synthesized in the liver and is the first line of defence against pro-
oxidant stress [231]. This antioxidant molecule is one of the main parts of the cellular 
endogenous antioxidant systems. It exerts its antioxidant function by donating electrons to 
radicals and changing to its oxidized form, which is subsequently reduced by the enzyme 
glutathione reductase [232].  
In contrast with our results, Das et al. [108] have reported increased GSH levels in the 
mitochondria of hypothyroid rat liver, while the results of Sarandol et al. [229] who didn’t 
observed any significant changes in GSH levels in the liver and kidney tissues of 
hypothyroid rats agree with our findings. The increase in GSH content in liver under the 
hypothyroid state may be an adaptive response to protect the mitochondria from the 
elevated level of H2O2. GSH is reported to be involved in numerous mitochondrial functions 
including mitochondrial membrane structure and integrity, ion homeostasis and 
mitochondrial redox state activity of numerous- SH- dependent enzymes [233]. The increase 
in the GSH level in mitochondria of hypothyroid rats may give protection to –SH- 
dependent proteins. In fact, the level of the increase in protein-SH groups in the 
hypothyroid state corroborates the above statement. GSH: GSSG in tissue is now considered 
one of the important markers of oxidative stress. The decrease in its ratio and the restoration 
to its normal value by T3 administration confirms the critical role of thyroid hormone in 
regulating mitochondrial oxidative stress [13].  
The organism can defend itself against the effects of oxidative stress by increasing SOD 
activity as a protection mechanism, but we did not observe any alteration in the serum and 
thyroid tissue of the hypothyroid rats. This is in line with the results of Messarah et al. [234] 
and[235] who observed no difference in SOD levels between hypothyroid rats and controls. 
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On the contrary, Das et al. [108] found increased SOD activity in the liver of hypothyroid 
rats which is accompanied with a decrease in catalase activity. SOD activity reduced and 
CAT activity increased following T3 administration to PTU-treated rats. It is apparent that 
SOD and CAT, the two principal enzymes responsible for the metabolism of hydrogen 
peroxide in liver, are under the regulatory influence of the thyroid status of the body. An 
increase in SOD activity in the hypothyroid state will accelerate the production of hydrogen 
peroxide while a decrease in catalase activity will slow down its moval. It is reported that 
production of superoxide radicals leads to the inactivation of catalase activity and the 
consequent accumulation of hydrogen peroxide causes inactivation of SOD [236]. In the 
study of [229] and [11], catalase activity levels were found to be decreased in the liver tissue 
of hypothyroid rats. In the case of the thyroid gland inhibition, one might expect a fall in 
cellular respiration and, by analogy, it does not have any effect on the SOD activity, 
showing the possible effect of thyroid hormones in the determination of the antioxidant 
enzyme levels. Similar assumptions have already been made by other authors [120,196].  
Venditti et al [110] have showed that antioxidants are not affected in the same manner in 
different tissues of hypothyroid rats; some of them increase, while several decrease or 
remain unchanged. The physiological state of the thyroid gland, the dose and the duration 
of treatment are also of a major influence on antioxidants enzymes.  
Vitamin E is a potent lipid soluble antioxidant in biological systems with the ability to 
directly quench free radicals and function as membrane stabilizer [237]. It protects and 
prohibits the propagation of lipid peroxidation, arising from oxidative stress.  
Data on the effects of vitamin E supplementation on thyroid hormone levels are limited.  
As far as the impact of vitamin E on thyroid status in L-thyroxine-treated rats is concerned, 
vitamin E supplementation caused a decrease in FT4 levels (p=0,000). These results show 
that Vitamin E has a thyroid function suppressing action. This is in line with the report of 
Seven et al. [141] who found decreased T4 and T3 levels in vitamin E-supplemented 
euthyroid rats and suggested that vitamin E supplementation in the euthyroid state 
decreases either T4/T3 synthesis or T4-T3 conversion. Further studies on deiodinase activity in 
liver tissue of hyperthyroidism-induced vitamin E-supplemented rats will clarify the crucial 
impact of vitamin E on T4-T3 conversion.  
Vitamin E supplementation significantly increased serum MDA levels in the Thyroxin 
treated group compared with the control group and with the only Thyroxin treated animals 
(p=0. 04). Carbonyl proteins levels in serum of the hyperthyroid supplemented rats were 
also increased compared with the controls (p=0. 0002). Antioxidant capacity markers in 
serum of group 3 were decreased compared with group 1. This could be explained by the 
relative doses of vitamin E administered as compared with other studies [141,205] which 
were not enough to suppress the oxidative stress in hyperthyroidism. Messarah et al [234] 
observed an increase in vitamin E concentrations in rats suffering from hyperthyroidism, 
which might be due to an adaptation against the oxidative stress provoked by the thyroid 
hyperactivity which could be the answer to our results.  
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In our study, vitamin E supplementation significantly increased serum and thyroid tissue 
protein carbonyls levels and decreased the levels of serum antioxidant markers SH, GSH and 
SOD in the Propylthiouracil treated group compared with the only Propylthiouracil treated 
rats. Significantly low levels of the SH groups (p<0. 05) were found in thyroid homogenates of 
the Propylthiouracil supplemented group as compared with the only Propylthiouracil treated 
rats. This could be explained by the relative doses of vitamin E administered, as compared 
with the study of Sarandol [229] which were not enough to suppress the oxidative stress in 
hypothyroid rats. For the first time in the literature, Erdamar et al [187] showed that the level 
of vitamin E was significantly increased in patients with hypothyroidism, which might be due 
to an adaptation against oxidative stress provoked by hypothyroidism.  
Under normal conditions there exists a delicate balance between the rate of formation of 
ROS and the rate of breakdown of ROS in mitochondria, which is under the subtle control of 
thyroid hormone. Any alteration in the thyroid state of the body will considerably influence 
the antioxidative status of mitochondria and can lead to a pathophysiological state.  
7. Conclusion 
Our results suggest that thyroid hormones in excess are accompanied by increased oxidative 
stress and impairment of the antioxidant system. Although it has been suggested that the 
hypometabolic state is associated with a decrease in oxidative stress, literature data are 
controversial, revealing an individuality of antioxidant status in relation to tissue properties 
and responsiveness. The present study confirmed an increased oxidative stress in 
hypothyroid state.  
Vitamin E supplementation in hyperthyroidism could exert beneficial effects in favour of the 
diminution of thyroid hormone levels. Antioxidants treatments might be helpful in reducing 
the oxidative damage due to hyperthyroidism. Therefore further studies have to be carried 
out on patients, in order to evaluate its role on antioxidant mechanisms to defend the 
organism from oxidative stress.  
Also, optimal dosage, route of administration and timing of antioxidant therapy should be 
determined. These findings indicate that thyroid hormones have a strong impact on 
oxidative stress and the antioxidant system.  
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